Checkpoint Therapeutics SG&A Expense (TTM) Trends

Checkpoint Therapeutics Inc (CKPT)

2.13 +0.08 (+3.90%) USD | NASDAQ | Jul 02, 16:00

2.13 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	8.844M
December 31, 2023	8.685M
September 30, 2023	9.291M
June 30, 2023	8.901M
March 31, 2023	8.749M
December 31, 2022	8.70M
September 30, 2022	8.346M
June 30, 2022	8.423M
March 31, 2022	8.408M
December 31, 2021	8.538M
September 30, 2021	8.534M
June 30, 2021	9.04M
March 31, 2021	8.613M
December 31, 2020	7.918M
September 30, 2020	7.946M
June 30, 2020	7.137M

Date	Value
March 31, 2020	7.208M
December 31, 2019	7.233M
September 30, 2019	6.583M
June 30, 2019	6.507M
March 31, 2019	6.101M
December 31, 2018	6.592M
September 30, 2018	6.445M
June 30, 2018	6.245M
March 31, 2018	6.21M
December 31, 2017	5.419M
September 30, 2017	5.154M
June 30, 2017	4.782M
March 31, 2017	4.686M
December 31, 2016	4.467M
September 30, 2016	5.533M
June 30, 2016	4.78M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.583M

Minimum

Sep 2019

9.291M

Maximum

Sep 2023

8.268M

Average

8.534M

Median

Sep 2021

SG&A Expense (TTM) Benchmarks